Your browser doesn't support javascript.
loading
The effects of T-DXd on the expression of HLA class I and chemokines CXCL9/10/11 in HER2-overexpressing gastric cancer cells.
Nakajima, Shotaro; Mimura, Kosaku; Matsumoto, Takuro; Thar Min, Aung Kyi; Ito, Misato; Nakano, Hiroshi; Neupane, Prajwal; Kanke, Yasuyuki; Okayama, Hirokazu; Saito, Motonobu; Momma, Tomoyuki; Watanabe, Yohei; Hanayama, Hiroyuki; Hayase, Suguru; Saze, Zenichiro; Kono, Koji.
  • Nakajima S; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Mimura K; Department of Obesity and Inflammation Research, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Matsumoto T; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Thar Min AK; Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Ito M; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Nakano H; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Neupane P; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Kanke Y; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Okayama H; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Saito M; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Momma T; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Watanabe Y; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Hanayama H; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Hayase S; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Saze Z; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
  • Kono K; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.
Sci Rep ; 11(1): 16891, 2021 08 19.
Article en En | MEDLINE | ID: mdl-34413454
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Camptotecina / Antígenos de Histocompatibilidad Clase I / Receptor ErbB-2 / Inmunoconjugados / Quimiocina CXCL9 / Quimiocina CXCL10 / Quimiocina CXCL11 / Trastuzumab Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Camptotecina / Antígenos de Histocompatibilidad Clase I / Receptor ErbB-2 / Inmunoconjugados / Quimiocina CXCL9 / Quimiocina CXCL10 / Quimiocina CXCL11 / Trastuzumab Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article